Revenue: The sum of all revenue fields included for a company's operating activities.
Nuvation Bio Inc. (NUVB) had Revenue of $41.87M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
|
Revenue |
$41.87M |
$-36.59M |
|
$1.28M |
|
$40.59M |
|
$75.90M |
|
$-34.04M |
|
$-2.56M |
|
$-36.59M |
|
$-36.59M |
|
$-36.59M |
|
$-36.59M |
|
$-36.59M |
|
$-36.59M |
|
$-34.04M |
|
$-33.17M |
|
341.54M |
|
341.54M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
$571.52M |
|
$0.56M |
|
$23.30M |
|
$594.82M |
|
$82.23M |
|
$47.21M |
|
$206.88M |
|
$289.11M |
|
$305.72M |
|
$294.50M |
|
$305.72M |
|
346.50M |
|
| Cash Flow Statement Financials | |
$-173.43M |
|
$99.52M |
|
$202.53M |
|
$35.72M |
|
$164.09M |
|
$128.36M |
|
$35.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.95 |
|
-- |
|
-- |
|
0.13 |
|
0.17 |
|
96.94% |
|
-81.30% |
|
-81.30% |
|
-- |
|
-87.40% |
|
-87.40% |
|
$-173.78M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.11 |
|
2.16 |
|
41.62 |
|
-11.97% |
|
-12.43% |
|
-6.15% |
|
-10.37% |
|
$0.88 |
|
$-0.51 |
|
$-0.51 |
|